Insider filing · HALO
Michael J. LaBarre
SVP, CHIEF TECHNICAL OFFICER
profile →
Halozyme Therapeutics, Inc.
HALO · Healthcare · 39 filings in 24 months
ticker →
Michael J. LaBarre sold $1.2M of Halozyme Therapeutics (HALO)
Executed Sep 17 2024, disclosed Sep 18 2024, 1 day later.
Value, as filed
$1.2M
20,000 sh across 3 lots
Executed
Sep 17 2024
the trade date, as filed
Disclosed
Sep 18 2024
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MLMichael J. LaBarre (SVP, CHIEF TECHNICAL OFFICER) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $1.1M of HALO (18,700 sh across 2 lots, as filed), executed Feb 25 2025.
The name
HALOHealthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael J. LaBarre in HALO
HALOSALE
Halozyme Therapeutics, Inc.
$1.1M18,700 sh across 2 lots
Exec Feb 25 2025
Filed Feb 27 2025 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. $1.1M
19,923 sh across 2 lots
Exec Oct 15 2024
Filed Oct 16 2024 · 5:30 PM ET